Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related MNKD
38 Biggest Movers From Yesterday
Applied Optoelectronics, Helios And Matheson Among The Top Stocks With Short Sellers
Related NVO
With New CEO In Place, Focus For Teva Pharma Turns To 'Execution'
A Look At Kare Schultz, The New CEO In Charge Of Teva
Novo Nordisk Gets FDA Panel's OK for Diabetes Drug (GuruFocus)

Analysts at Bank of America downgraded MannKind (NASDAQ: MNKD) from “neutral” to “underperform.” The target price for MannKind has been lowered from $8 to $5. MannKind's shares closed at $6.30 yesterday.

Swedbank downgraded Novo Nordisk A/S (NYSE: NVO) from “strong buy” to “buy.” Novo Nordisk's shares closed at $162.53 yesterday.

SunTrust Robinson Humphrey downgraded Bank of the Ozarks (NASDAQ: OZRK) from “buy” to “neutral.” The target price for Bank of the Ozarks has been raised from $46 to $49. Bank of the Ozarks' shares closed at $46.01 yesterday.

Analysts at Credit Suisse downgraded M&T Bank (NYSE: MTB) from “outperform” to “neutral.” M&T Bank's shares closed at $115.91 yesterday.

Latest Ratings for MNKD

DateFirmActionFromTo
Oct 2017H.C. WainwrightInitiates Coverage OnBuy
Aug 2017Maxim GroupInitiates Coverage OnBuy
Nov 2015Griffin SecuritiesDowngradesBuyNeutral

View More Analyst Ratings for MNKD
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (MNKD + MTB)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...